{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T10:47:49Z","timestamp":1774003669039,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100024214","name":"Funda\u00e7\u00e3o de Desenvolvimento da Unicamp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100024214","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003100","name":"F\u00e9d\u00e9ration Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.exphem.2025.105366","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T19:12:05Z","timestamp":1767208325000},"page":"105366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Anti-IL-18 immunotherapy decreases inflammatory and vaso-occlusive responses in mice with sickle cell disease"],"prefix":"10.1016","volume":"156","author":[{"given":"\u00c9rica M.F.","family":"Gotardo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4598-1899","authenticated-orcid":false,"given":"Lidiane S.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7644-5642","authenticated-orcid":false,"given":"Irmgard","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9143-3706","authenticated-orcid":false,"given":"Lucas F.S.","family":"Gushiken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6319-4760","authenticated-orcid":false,"given":"P\u00e2mela L.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia C.","family":"Leonardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7926-5199","authenticated-orcid":false,"given":"Bruna Cunha","family":"Zaidan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Bruederle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei","family":"Agoulnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2267-4673","authenticated-orcid":false,"given":"Jiri","family":"Kovarik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Millholland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Conran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2025.105366_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.exphem.2025.105366_bib0002","doi-asserted-by":"crossref","first-page":"e633","DOI":"10.1016\/S2352-3026(23)00096-0","article-title":"Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission","volume":"10","author":"Piel","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.exphem.2025.105366_bib0003","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41584-023-01053-w","article-title":"Biological and clinical roles of IL-18 in inflammatory diseases","volume":"20","author":"Landy","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.exphem.2025.105366_bib0004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0022-1759(01)00505-1","article-title":"Generation of neutralizing mouse anti-mouse IL-18 antibodies for inhibition of inflammatory responses in vivo","volume":"259","author":"Lochner","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.exphem.2025.105366_bib0005","article-title":"ASC-independent caspase-1 activation in neutrophils from patients with sickle cell anemia","volume":"29","author":"Mendon\u00e7a","year":"2018","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.exphem.2025.105366_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.954054","article-title":"Are IL-1 family cytokines important in management of sickle cell disease in sub-Saharan Africa patients?","volume":"14","author":"Siransy","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2025.105366_bib0007","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1111\/bjh.19970","article-title":"Plasma inflammatory and angiogenic protein profiling of patients with sickle cell disease","volume":"206","author":"de Ligt","year":"2025","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2025.105366_bib0008","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1182\/blood.2020005944","article-title":"IL-18 mediates sickle cell cardiomyopathy and ventricular arrhythmias","volume":"137","author":"Gupta","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105366_bib0009","doi-asserted-by":"crossref","unstructured":"Wagdy R, Assem H, Abd-Elmohsen AM, Fata A, Gendy WE, Gaber M. Altered ventricular longitudinal strain in children with sickle cell disease: role of TGF-beta and IL-18. Pediatr Blood Cancer. 2024;71:e30762. doi:10.1002\/pbc.30762","DOI":"10.1002\/pbc.30762"},{"key":"10.1016\/j.exphem.2025.105366_bib0010","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1182\/blood-2006-02-004812","article-title":"Correction of sickle cell disease by homologous recombination in embryonic stem cells","volume":"108","author":"Wu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105366_bib0011","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.278.5339.876","article-title":"Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease","volume":"278","author":"P\u00e1szty","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.exphem.2025.105366_bib0012","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.89761","article-title":"Lung vaso-occlusion in sickle cell disease mediated by arteriolar neutrophil-platelet microemboli","volume":"2","author":"Bennewitz","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.exphem.2025.105366_bib0013","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S1734-1140(09)70004-0","article-title":"ICAM-1 signaling in endothelial cells","volume":"61","author":"Lawson","year":"2009","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.exphem.2025.105366_bib0014","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nmeth1018","article-title":"Imaging receptor microdomains on leukocyte subsets in live mice","volume":"4","author":"Chiang","year":"2007","journal-title":"Nat Methods"},{"key":"10.1016\/j.exphem.2025.105366_bib0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: biological role in induction, regulation, and treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.exphem.2025.105366_bib0016","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1074-7613(00)80596-8","article-title":"Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function","volume":"9","author":"Adachi","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2025.105366_bib0017","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1074\/jbc.M510797200","article-title":"Tumor necrosis factor-alpha-converting enzyme (TACE\/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1)","volume":"281","author":"Tsakadze","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2025.105366_bib0018","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1182\/blood-2005-07-2839","article-title":"Pathology of Berkeley sickle cell mice: similarities and differences with human sickle cell disease","volume":"107","author":"Manci","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2025.105366_bib0019","first-page":"725","article-title":"Targeting P-selectin and interleukin-1\u03b2 in mice with sickle cell disease: effects on vaso-occlusion, liver injury and organ iron deposition","volume":"110","author":"Gotardo","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.exphem.2025.105366_bib0020","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.4049\/jimmunol.171.2.1009","article-title":"IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4","volume":"171","author":"Canetti","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2025.105366_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115861","article-title":"NLRP3 inflammasome in hepatic diseases: A pharmacological target","volume":"217","author":"Ramos-Tovar","year":"2023","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.exphem.2025.105366_bib0022","doi-asserted-by":"crossref","first-page":"H920","DOI":"10.1152\/ajpheart.00197.2025","article-title":"Caspase-1 activation drives vascular inflammatory processes and hypoperfusion in intravascular hemolysis","volume":"329","author":"Brito","year":"2025","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.exphem.2025.105366_bib0023","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11883-018-0754-6","article-title":"Examining the role of and treatment directed at IL-1beta in atherosclerosis","volume":"20","author":"Khan","year":"2018","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.exphem.2025.105366_bib0024","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1586\/17476348.2015.1063422","article-title":"IL-1beta: a key modulator in asthmatic airway smooth muscle hyper-reactivity","volume":"9","author":"Liao","year":"2015","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.exphem.2025.105366_bib0025","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1007\/s00018-013-1425-y","article-title":"IL-18 in inflammatory and autoimmune disease","volume":"70","author":"Sedimbi","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.exphem.2025.105366_bib0026","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCRESAHA.112.266411","article-title":"Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcgammaRIII and SHP-1","volume":"110","author":"Jang","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.exphem.2025.105366_bib0027","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ajh.23649","article-title":"Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15","volume":"89","author":"Fertrin","year":"2014","journal-title":"Am J Hematol"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X25006459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T08:30:06Z","timestamp":1773995406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X25006459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":27,"alternative-id":["S0301472X25006459"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105366","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-IL-18 immunotherapy decreases inflammatory and vaso-occlusive responses in mice with sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2025.105366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105366"}}